Builders have a unique opportunity to revolutionize the field by enhancing our ability to engineer biology. By improving manufacturing processes and the precision of programmable medicines, we can tackle issues related to cost, permanence, and toxicity. This advancement promises to deliver better applications at scale, ultimately bringing solutions to patients more swiftly.
